Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2004 | 10-2003 | 10-2002 | 10-2001 | 10-2000 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 44 | 44 | 153 | 208 | 220 |
| Accounts receivable | -11 | 34 | -43 | 95 | N/A |
| Other Working Capital | 32 | 37 | 48 | 120 | 82 |
| Other Operating Activity | -37 | -75 | -219 | -598 | -308 |
| Operating Cash Flow | $29 | $41 | $-61 | $-175 | $-7 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15 | -58 | N/A | -29 | N/A |
| Net Acquisitions | N/A | N/A | N/A | N/A | -17 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 38 |
| Investing Cash Flow | $-15 | $-58 | $0 | $-29 | $21 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 100 | 180 | N/A |
| Other Financing Activity | 35 | -7 | 46 | 3 | 0 |
| Financing Cash Flow | $35 | $-7 | $146 | $183 | $0 |
| Beginning Cash Position | 36 | 61 | -25 | 21 | 6 |
| End Cash Position | 85 | 36 | 61 | 0 | 21 |
| Net Cash Flow | $49 | $-25 | $85 | $-20 | $14 |
| Free Cash Flow | |||||
| Operating Cash Flow | 29 | 41 | -61 | -175 | -7 |
| Capital Expenditure | -15 | -58 | N/A | -29 | N/A |
| Free Cash Flow | 14 | -18 | -61 | -204 | -7 |